-+ 0.00%
-+ 0.00%
-+ 0.00%

KODIAK SCIENCES SHARES UP 123% AFTER CO'S EYE-DISEASE DRUGS MEET TRIAL GOALS

Reuters·09/28/2026 13:44:08